open access

Vol 4, No 3 (2002)
Published online: 2002-11-08
Get Citation

Surgery for cardiac myxomas - a 20-year experience with transseptal approach

Bartłomiej Perek, Marek Jemielity, Sławomir Katarzyński, Marcin Misterski, Wojciech Dyszkiewicz
Chirurgia Polska 2002;4(3):125-131.

open access

Vol 4, No 3 (2002)
Published online: 2002-11-08

Abstract

Introduction: Cardiac myxomas are the most common primary cardiac tumours. The aim of this study was to assess the early and late results of surgical resection of cardiac myxomas with the use of transseptal technique.
Material and methods: Between 1981 and 2001, 23 patients (9 M/14 F) at mean age 44.7 ± 13.5 years (ranging from 21 to 74 years) were operated on. The myxomas were located in the left atrium in 18 cases (78.3%), in the right atrium in 3 patients (13.0%) and in both atria or in the right ventricle in single cases. All patients were operated on from median sternotomy in moderate hypothermia (26–28°C) with the use of cardiopulmonary bypass. Method of right atriotomy with transseptal incision was used. At the end of follow-up, clinical and echocardiographic examination (M + 2D + Doppler) were performed.
Results: One patient (4.3%) died in hospital. The mean follow-up of 5.8 ± 3.8 years (range from 3 months to 21 years) was completed by all patients. Two patients died during follow-up for noncardiac-related reasons. No tumour recurrences were observed. The cumulative survival rate calculated from the Kaplan-Meier curve was 85.3% after 5 years. At the end of follow-up all patients were in NYHA classes I or II.
Conclusions: Surgical resection of myxoma using transseptal approach is safe and effective with a low risk of recurrence.

Abstract

Introduction: Cardiac myxomas are the most common primary cardiac tumours. The aim of this study was to assess the early and late results of surgical resection of cardiac myxomas with the use of transseptal technique.
Material and methods: Between 1981 and 2001, 23 patients (9 M/14 F) at mean age 44.7 ± 13.5 years (ranging from 21 to 74 years) were operated on. The myxomas were located in the left atrium in 18 cases (78.3%), in the right atrium in 3 patients (13.0%) and in both atria or in the right ventricle in single cases. All patients were operated on from median sternotomy in moderate hypothermia (26–28°C) with the use of cardiopulmonary bypass. Method of right atriotomy with transseptal incision was used. At the end of follow-up, clinical and echocardiographic examination (M + 2D + Doppler) were performed.
Results: One patient (4.3%) died in hospital. The mean follow-up of 5.8 ± 3.8 years (range from 3 months to 21 years) was completed by all patients. Two patients died during follow-up for noncardiac-related reasons. No tumour recurrences were observed. The cumulative survival rate calculated from the Kaplan-Meier curve was 85.3% after 5 years. At the end of follow-up all patients were in NYHA classes I or II.
Conclusions: Surgical resection of myxoma using transseptal approach is safe and effective with a low risk of recurrence.
Get Citation

Keywords

cardiac myxoma; surgical treatment; transseptal approach

About this article
Title

Surgery for cardiac myxomas - a 20-year experience with transseptal approach

Journal

Chirurgia Polska (Polish Surgery)

Issue

Vol 4, No 3 (2002)

Pages

125-131

Published online

2002-11-08

Bibliographic record

Chirurgia Polska 2002;4(3):125-131.

Keywords

cardiac myxoma
surgical treatment
transseptal approach

Authors

Bartłomiej Perek
Marek Jemielity
Sławomir Katarzyński
Marcin Misterski
Wojciech Dyszkiewicz

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

Via MedicaBy "Via Medica sp. z o.o." sp.k., ul. Świętokrzyska 73, 80–180 Gdańsk

tel.:+48 58 320 94 94, faks:+48 58 320 94 60, e-mail: viamedica@viamedica.pl